Rani Therapeutics Holdings Inc (RANI) — Cash Flow-to-Debt Ratio
Rani Therapeutics Holdings Inc (RANI) has a Cash Flow-to-Debt Ratio of -0.23x as of September 2025, meaning its operating cash flow of $-5.06 Million could theoretically repay 0% of its total liabilities ($22.11 Million) in one year. Check cash flow reinvestment rate of Rani Therapeutics Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Rani Therapeutics Holdings Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Rani Therapeutics Holdings Inc across 6 annual periods. Also explore RANI total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Rani Therapeutics Holdings Inc (2019–2024)
Year-by-year debt coverage analysis for Rani Therapeutics Holdings Inc. For market capitalisation and broader financial context, see Rani Therapeutics Holdings Inc (RANI) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.07x | $-35.50 Million | $33.14 Million | ▲ +32.1% |
| 2023 | -1.58x | $-51.24 Million | $32.47 Million | ▼ -15.4% |
| 2022 | -1.37x | $-46.52 Million | $34.02 Million | ▲ +88.8% |
| 2021 | -12.21x | $-32.24 Million | $2.64 Million | ▼ -15637.3% |
| 2020 | -0.08x | $-14.96 Million | $192.75 Million | ▲ +64.6% |
| 2019 | -0.22x | $-26.27 Million | $119.66 Million | — |